The GLP is committed to full transparency. Download and review our 2019 Annual Report

Stem cell supplement approved in Taiwan

| September 6, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

RBC Life Sciences, Inc. (OTCQB: RBCL) announced today that the Company’s stem cell supplement, Stem-Kine™, has been approved for importation and sale in Taiwan. Stem-Kine is marketed in Taiwan under the name SK Plus.

Stem cells are early stage cells, formed primarily in bone marrow that can develop into any type of cell — heart, brain, or other tissues. Stem cells circulate with the blood, congregating in diseased or damaged tissues, where they replace the injured cells with healthy new cells. 

Stem cells form the body’s internal repair and rejuvenation system. Physicians consistently report that a greater number of the body’s own adult stem cells results in more effective repair.

Related article:  Preponderance of field studies and latest research still concludes bees not disappearing

View the original article here: Stem Cell Supplement Approved In Taiwan – Sacramento Bee

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend